Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Expert Opinion / Cases · April 03, 2017

Adjuvant Therapy for Triple Positive Breast Cancer With Diabetic Neuropathy

 

Discuss This item Follow

No comments yet, be the first to start the discussion!

  • James Cohen

    Apr 08, 2017

    Dose dense plus herceptin

  • mohamed lemine sow

    Apr 08, 2017

    of course she is not candidate for the taxane,the option are anthtracyline then herceptin then RTH and hormonotherapy

  • Dec 23, 2024

    Pending Moderator approval.
    Delete

Further Reading